Inloggen met DigiD
Download de MijnOLVG-app in de App Store of Google Play Store of ga naar www.mijnolvg.nl. Log daarna eenvoudig in met uw DigiD.
Veel gezocht: Vacatures, Orthopedie, Bloedafname
MijnOLVG is het patiƫntenportaal van OLVG. In MijnOLVG kunt u uw medische gegevens zien. Op elk moment, wanneer het u uitkomt. OLVG breidt MijnOLVG steeds verder uit, zodat u zelf meer digitaal kunt regelen. Met MijnOLVG kunnen we u sneller helpen.
BACKGROUND: Transcervical resection of myoma or endometrium is a safe, hysteroscopic, minimally invasive procedure. However, intravasation of distension fluid is a common phenomenon during these procedures. In a previous study we observed venous gas emboli in almost every patient. The severity of hysteroscopic-derived embolization has been shown to be correlated to the amount of intravasation. In addition, paradoxical gas embolism, which is potentially dangerous, was observed in several patients. Studies have shown a reduction of intravasation by using intracervically administered vasopressin during hysteroscopy. We think that its analog, terlipressin, should have the same effect. In our previous research we observed more gaseous emboli as intravasation increased. Whether or not the insertion of intracervically administered terlipressin leads to a lower incidence and severity of gas embolism is unknown. We hypothesize that intracervically administered terlipressin leads to a reduction of intravasation with a lower incidence and severity of gas embolism. Terlipressin may be of benefit during hysteroscopic surgery. METHODS/DESIGN: Forty-eight patients (ASA 1 or 2) scheduled for transcervical resection of large, types 1-2 myoma or extensive endometrium resection will be included. In a double-blind fashion patients will be randomized 1:1 according to surgical treatment using either intracervically administered terlipressin or placebo. Transesophageal echocardiography will be used to observe and record embolic events. A pre- and post-procedure venous blood sample will be taken to calculate intravasation based on hemodilution. Our primary endpoint will be how terlipressin influences the severity of embolic events. Secondary endpoints include the effect of terlipressin on the amount of intravasation and on hemodynamic parameters. DISCUSSION: If terlipressin does indeed reduce the number of gaseous emboli and intravasation occurring during hysteroscopic surgery, it would be a simple method to minimize potential adverse events. It also allows for prolonged operating time before the threshold of intravasation is reached, thereby reducing the need for a second operation. TRIAL REGISTRATION: Nederlands Trial Register (Dutch Trial Register), ID: NTR5577 . Registered retrospectively on 18 December 2015.
For translating the text, please follow the instructions below:
1. Select the text you want to translate.
2. Choose 'Vertalen'.
3. Select the preferred language.
4. You can now read and/or listen to the translated text.
Please note that the text has been translated using third-party software. The most accurate translation possible was generated; however, no automated translation is perfect, and automated translations are not a replacement for human translators. Translations are offered as a service to the users of this website. There is no guarantee that the translation will be accurate, reliable or correct. OLVG is in no way responsible for the actual translation. If you have any questions, you should always consult your doctor.
Met "compleet" werkt alles het best. Maar je kunt ook kiezen voor een ander niveau. Je keuze kun je natuurlijk altijd aanpassen.